CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Xbiotech Inc.  (XBIT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Xbiotech's Leverage Ratio

XBIT's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

XBIT Leverage Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Equity Change -11.65 % -13.11 % -42.68 % -37.21 % -33.21 %
Y / Y Total Liabilities Change -54.94 % -18.79 % 24.2 % 34.06 % 262.01 %
Leverage Ratio MRQ 0.06 0.06 0.14 0.09 0.13
Overall Ranking # 70 # 109 # 0 # 0 # 0
Seq. Equity Change -11.08 % 39.29 % -17.54 % -13.5 % -12.54 %
Seq. Total Liabilities Change -12.36 % -33.06 % 19.86 % -35.91 % 57.94 %



Leverage Ratio second quarter 2017 Comment
Due to repayements of liabilities of -12.36% Xbiotech improved Leverage Ratio in second quarter 2017 to 0.06, below company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the second quarter 2017, 16 other companies have achieved lower Leverage Ratio than Xbiotech. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are XBIT Customers?
Leverage Ratio second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 17
Healthcare Sector # 27
Overall Market # 70


Leverage Ratio Statistics
High Average Low
0.14 0.08 0.02
(Dec 31 2016)   (Jun 30 2015)


You need to upgrade your Flash Player


Financial Statements
Xbiotech's Equity $ 73 Millions Visit XBIT's Balance sheet
Xbiotech's Total Liabilities $ 5 Millions Visit XBIT's Balance sheet
Source of XBIT's Sales Visit XBIT's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2017, within Major Pharmaceutical Preparations Industry Leverage RatioJun 30 2017 MRQ Total LiabilitiesJun 30 2017 MRQ Equity
Five Prime Therapeutics Inc  0.18 $ 56.837  Millions$ 323.274  Millions
Stemline Therapeutics Inc  0.18 $ 14.000  Millions$ 79.973  Millions
Cellectar Biosciences, Inc.  0.16 $ 1.737  Millions$ 10.865  Millions
Ultragenyx Pharmaceutical Inc.  0.16 $ 68.089  Millions$ 429.453  Millions
Ovascience, Inc.  0.16 $ 12.744  Millions$ 81.141  Millions
Radius Health, Inc.  0.15 $ 32.105  Millions$ 207.320  Millions
Medicinova Inc  0.15 $ 5.070  Millions$ 33.386  Millions
Revance Therapeutics, Inc.  0.15 $ 24.112  Millions$ 159.414  Millions
Esperion Therapeutics, Inc.  0.15 $ 22.871  Millions$ 154.107  Millions
Prothena Corp Plc  0.15 $ 71.225  Millions$ 486.976  Millions
Mirati Therapeutics, Inc.  0.14 $ 12.017  Millions$ 82.967  Millions
Therapeuticsmd, Inc.  0.14 $ 13.288  Millions$ 93.590  Millions
Aldeyra Therapeutics, Inc.  0.13 $ 3.128  Millions$ 23.340  Millions
Nivalis Therapeutics, Inc.  0.13 $ 6.162  Millions$ 46.066  Millions
Ardelyx, Inc.  0.13 $ 19.144  Millions$ 144.978  Millions
Sage Therapeutics, Inc.  0.13 $ 33.108  Millions$ 260.304  Millions
Chiasma, Inc  0.12 $ 8.947  Millions$ 74.101  Millions
Myovant Sciences Ltd.  0.12 $ 17.417  Millions$ 145.982  Millions
Lipocine Inc.  0.12 $ 2.900  Millions$ 25.148  Millions
Karyopharm Therapeutics Inc.  0.11 $ 19.036  Millions$ 166.714  Millions
Neurotrope, Inc.  0.11 $ 2.184  Millions$ 19.484  Millions
Sciclone Pharmaceuticals Inc  0.11 $ 27.744  Millions$ 249.867  Millions
Zynerba Pharmaceuticals, Inc.  0.11 $ 7.864  Millions$ 71.229  Millions
Madrigal Pharmaceuticals, Inc.  0.10 $ 6.436  Millions$ 61.631  Millions
Moleculin Biotech, Inc.  0.10 $ 1.980  Millions$ 19.269  Millions
Vital Therapies Inc  0.10 $ 7.338  Millions$ 73.337  Millions
Acadia Pharmaceuticals Inc  0.10 $ 41.175  Millions$ 415.140  Millions
Abeona Therapeutics Inc.  0.09 $ 7.581  Millions$ 89.078  Millions
Aimmune Therapeutics, Inc.  0.08 $ 19.563  Millions$ 236.791  Millions
Otonomy, Inc.  0.08 $ 11.624  Millions$ 150.062  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
WCRS's Profile
Stock Price
WCRS's Financials
WCRS's Expectations
Business Description
Fundamentals
Charts & Quotes
WCRS's News
Suppliers
WCRS's Competitors
Customers & Markets
Economic Indicators
WCRS's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com